S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.14
-6.4%
$0.17
$0.13
$33.44
$4.52M0.674.69 million shs1.35 million shs
Remedent, Inc. stock logo
REMI
Remedent
$0.06
$0.06
$0.00
$0.17
$1.10M-0.241,153 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
+1.09%-0.60%+6.07%-83.22%-99.56%
Remedent, Inc. stock logo
REMI
Remedent
0.00%-15.84%-30.38%-26.67%-67.65%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.1076 of 5 stars
2.02.00.00.00.60.00.0
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/A$77.0055,295.68% Upside
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$49.16M0.09N/AN/A($0.07) per share-1.99
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$32.58N/AN/A-41.97%-555.22%-53.10%5/9/2024 (Estimated)
Remedent, Inc. stock logo
REMI
Remedent
N/AN/A0.00N/AN/AN/AN/AN/A

Latest BIOL and REMI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A-$1.76-$1.76-$1.76N/A$13.49 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
34.06
1.26
0.68
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Remedent, Inc. stock logo
REMI
Remedent
N/A

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.27%
Remedent, Inc. stock logo
REMI
Remedent
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
15732.52 million32.44 millionNot Optionable
Remedent, Inc. stock logo
REMI
Remedent
320.00 millionN/ANot Optionable

BIOL and REMI Headlines

SourceHeadline
Remi LambertRemi Lambert
thesun.co.uk - February 29 at 1:58 AM
Peterson RemyPeterson Remy
health.usnews.com - February 15 at 6:43 AM
Remi MonaghanRemi Monaghan
fox17online.com - January 10 at 8:33 AM
remy ma and papooseremy ma and papoose
hiphopwired.com - December 7 at 12:39 AM
Rémi Bonnet Breaks Longtime Pikes Peak Ascent RecordRémi Bonnet Breaks Longtime Pikes Peak Ascent Record
runnersworld.com - September 25 at 3:52 PM
Home and Away spoiler: Remi keeps quiet about the kissHome and Away spoiler: Remi keeps quiet about the kiss
digitalspy.com - August 20 at 5:02 PM
Remi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: Stream
yahoo.com - June 2 at 5:49 PM
Home and Away spoilers: Remi collapses in Salt as his injury worsensHome and Away spoilers: Remi collapses in Salt as his injury worsens
metro.co.uk - March 27 at 10:37 PM
Love Island star Remi Lambert claims he was assaulted by one of Jacques ONeills friendsLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friends
mirror.co.uk - March 22 at 10:02 AM
Remi Matthews focuses on the present with St JohnstoneRemi Matthews focuses on the present with St Johnstone
irishnews.com - March 17 at 6:45 PM
Lioness of Bourdillon: How Remi Tinubu Becomes the New Beautiful BrideLioness of Bourdillon: How Remi Tinubu Becomes the New Beautiful Bride
thisdaylive.com - March 7 at 6:44 PM
Remi Bader shares what happened to her when she stopped taking OzempicRemi Bader shares what happened to her when she stopped taking Ozempic
today.com - February 5 at 10:54 PM
‘Most female colleagues have Sugar Daddy,’ Anita Joseph replies Kunle Remi‘Most female colleagues have Sugar Daddy,’ Anita Joseph replies Kunle Remi
vanguardngr.com - January 28 at 1:19 PM
Where is Remi Adeleke and who is Chris Oliver from SAS: Who Dares Wins?Where is Remi Adeleke and who is Chris Oliver from SAS: Who Dares Wins?
uk.news.yahoo.com - January 25 at 7:36 PM
Meet Remi, the pet of the week available for adoption at the Nebraska Humane SocietyMeet Remi, the pet of the week available for adoption at the Nebraska Humane Society
ketv.com - January 16 at 7:49 PM
Remi Bader Says She Gained Double the Weight Back After Stopping Weight-Loss Drug OzempicRemi Bader Says She 'Gained Double the Weight Back' After Stopping Weight-Loss Drug Ozempic
people.com - January 13 at 10:26 AM
VN ticker: Cavagna turns page on surgery, CPA to elect new presidentVN ticker: Cavagna turns page on surgery, CPA to elect new president
velonews.com - January 12 at 1:18 PM
Remi Harris and Tom MooreRemi Harris and Tom Moore
music-news.com - November 19 at 7:02 PM
Cathedral of Notre-Dame, Former Abbey of Saint-Rémi and Palace of Tau, ReimsCathedral of Notre-Dame, Former Abbey of Saint-Rémi and Palace of Tau, Reims
whc.unesco.org - October 18 at 6:31 AM
Pet of the week: Meet RemiPet of the week: Meet Remi
bucyrustelegraphforum.com - October 4 at 4:47 PM
Remedent, Inc. (REMI)Remedent, Inc. (REMI)
finance.yahoo.com - August 22 at 8:38 PM
Remedent Year to Date Total Returns (Daily)Remedent Year to Date Total Returns (Daily)
ycharts.com - January 4 at 8:10 AM
Remedent Dividend Per Share (TTM)Remedent Dividend Per Share (TTM)
ycharts.com - January 4 at 8:10 AM
Remedent Inc.Remedent Inc.
barrons.com - August 21 at 11:06 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BIOLASE logo

BIOLASE

NASDAQ:BIOL
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Remedent logo

Remedent

OTCMKTS:REMI
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.